BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29955483)

  • 1. Brain-derived neurotrophic factor and schizophrenia.
    Gören JL
    Ment Health Clin; 2016 Nov; 6(6):285-288. PubMed ID: 29955483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions.
    Begni V; Riva MA; Cattaneo A
    Clin Sci (Lond); 2017 Jan; 131(2):123-138. PubMed ID: 28011898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Brain-derived neurotrophic factor: from nerve growth factor to modulator of brain plasticity in cognitive processes and psychiatric diseases].
    Laske C; Eschweiler GW
    Nervenarzt; 2006 May; 77(5):523-37. PubMed ID: 16078056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor heterozygous mutant rats show selective cognitive changes and vulnerability to chronic corticosterone treatment.
    Gururajan A; Hill RA; van den Buuse M
    Neuroscience; 2015 Jan; 284():297-310. PubMed ID: 25445195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDNF-Val66Met-polymorphism impact on cortical plasticity in schizophrenia patients: a proof-of-concept study.
    Strube W; Nitsche MA; Wobrock T; Bunse T; Rein B; Herrmann M; Schmitt A; Nieratschker V; Witt SH; Rietschel M; Falkai P; Hasan A
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25612896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia.
    Angelucci F; Mathé AA; Aloe L
    Prog Brain Res; 2004; 146():151-65. PubMed ID: 14699963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse glial cell line-derived neurotrophic factor (GDNF) support between mania and schizophrenia: a comparative study in four major psychiatric disorders.
    Tunca Z; Kıvırcık Akdede B; Özerdem A; Alkın T; Polat S; Ceylan D; Bayın M; Cengizçetin Kocuk N; Şimşek S; Resmi H; Akan P
    Eur Psychiatry; 2015 Feb; 30(2):198-204. PubMed ID: 25543333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory.
    Nieto R; Kukuljan M; Silva H
    Front Psychiatry; 2013; 4():45. PubMed ID: 23785335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences and the role of estrogen in animal models of schizophrenia: interaction with BDNF.
    Wu YC; Hill RA; Gogos A; van den Buuse M
    Neuroscience; 2013 Jun; 239():67-83. PubMed ID: 23085218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.
    Skibinska M; Groszewska A; Kapelski P; Rajewska-Rager A; Pawlak J; Dmitrzak-Weglarz M; Szczepankiewicz A; Twarowska-Hauser J
    Pharmacol Rep; 2018 Feb; 70(1):55-59. PubMed ID: 29331787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.
    Gama CS; Andreazza AC; Kunz M; Berk M; Belmonte-de-Abreu PS; Kapczinski F
    Neurosci Lett; 2007 Jun; 420(1):45-8. PubMed ID: 17442489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia.
    Nurjono M; Lee J; Chong SA
    Clin Psychopharmacol Neurosci; 2012 Aug; 10(2):61-70. PubMed ID: 23431036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BDNF as a biomarker in the course and treatment of schizophrenia.
    Libman-Sokołowska M; Drozdowicz E; Nasierowski T
    Psychiatr Pol; 2015; 49(6):1149-58. PubMed ID: 26909392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review.
    Notaras M; Hill R; van den Buuse M
    Neurosci Biobehav Rev; 2015 Apr; 51():15-30. PubMed ID: 25562189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes.
    Zakharyan R; Boyajyan A
    Clin Biochem; 2014 Aug; 47(12):1052-5. PubMed ID: 24713399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.
    Xiao W; Ye F; Liu C; Tang X; Li J; Dong H; Sha W; Zhang X
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():163-168. PubMed ID: 28342945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
    Hashim HM; Fawzy N; Fawzi MM; Karam RA
    J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.